$4.23
0.071.68%
Last update: Oct 29, 4:34 AM
Oramed Pharmaceuticals Inc
ORMPNASDAQ
Oramed Pharmaceuticals (ORMP) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.43 | $-0.08 | $-0.03 | $-0.08 |
| Actual | $1.84 | $0.91 | $0.24 | $1.26 |
| Surprise | +327.9% | +1237.5% | +900.0% | +1675.0% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $2.0M |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $0.43 | $0.37 |
| Revenue | ||
| Consensus | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $1.84 | $0.43 | 327.9 % |
| Q1 | May 19, 2026 | $0.91 | $-0.08 | 1237.5 % |
| Q4 | Mar 25, 2026 | $0.24 | $-0.03 | 900.0 % |
| Q3 | Nov 13, 2025 | $1.26 | $-0.08 | 1675.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | May 15, 2025 | $2.00M | $500.00K | 300.0 % |
| Q2 | Aug 16, 2024 | $0 | $250.00K | -100.0 % |
| Q3 | Nov 9, 2023 | $0 | $700.00K | -100.0 % |
| Q2 | Aug 10, 2023 | $674.00K | $700.00K | -3.71 % |
